Whitepaper
Automation driven GxP services
The brochure highlights Somru BioScience’s services in drug discovery, biosimilar development, cell and gene therapy, vaccine development, and immunogenicity assessment. The company uses advanced bioanalytical methods and proprietary technologies to support preclinical and clinical studies, including in vivo experiments and immunological fingerprinting. They also offer automation-driven GxP services and large molecule bioanalytical services, emphasizing quality and speed.
Somru BioScience is located in Charlottetown, Prince Edward Island, Canada, and offers consultation through their team of experienced scientists and engineers.
Explore the Full Whitepaper !
The road to biosimilarity is paved with successful immunogenicity prediction and confirmation
Learn.
Engage.
Connect.
Learn | Engage | Connect
Read news, updates, and transforming technologies of drug development
Somru White Paper
Add Your Heading Text Here Click here
Read More ...A comprehensive bioanalytical solution
Somru developed the following comprehensive list of bioanalytical assays to support..
Read More ...17 March 2025 AI-Driven
17 March AI-Driven Compliance Webinar Our technical leaders would love..
Read More ...